The correlations of glucocorticoid receptor expression and traumatic experiences (Traumatic Experiences Questionnaire TQ), depression (Montgomery-Asberg Depression Scale, MADRS) and anxiety (Hamilton Anxiety Scale, HARS) symptomatology, was investigated in BPD patients controlling for the effect of antipsychotic medication (Table 2). The gene discussed is NR3C1; the disease is depressive symptom measurement.